RODARI NEWMAN: Open Payments
NPI 1437554953 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$474 in 26 payments from 10 companies in 2025. Trend: 2023 $168 · 2024 $44 · 2025 $474
Food & beverage: $474
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $106 |
| AstraZeneca Pharmaceuticals LP | 5 | $83 |
| Amgen Inc. | 4 | $71 |
| Abbott Laboratories | 3 | $58 |
| Inspire Medical Systems, Inc. | 2 | $49 |
| PFIZER INC. | 2 | $41 |
| Exact Sciences Corporation | 1 | $19 |
| Lilly USA, LLC | 1 | $17 |
| Seqirus USA Inc | 1 | $16 |
| Dexcom, Inc. | 1 | $14 |
Products named: REPATHA, Ozempic, FREESTYLE LIBRE 3, AIRSUPRA, INSPIRE, PREVNAR 20, BREZTRI, Wegovy.
Industry payments across TX — which companies pay providers there.
